Pfizer’s Dramatic Fall: A Golden Opportunity or a Risky Gamble?
Pfizer's stock price has dropped nearly 60% since late 2022, presenting a potential investment opportunity despite current uncertainties. Key challenges include looming patent expirations for major drugs like Eliquis and…